Quick Answer
Pyxis Oncology, Inc. reported Shares Outstanding of 62.69 million shares for fiscal year 2025.
Pyxis Oncology, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 62.69M | +4.5% |
| 2024 | 59.97M | +34.0% |
| 2023 | 44.75M | +28.0% |
| 2022 | 34.96M | +8.5% |
| 2021 | 32.22M | +2399.2% |
| 2020 | 1.29M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 62.15M | +4.5% | +0.2% |
| June 30, 2025 | 62.02M | +5.3% | +0.6% |
| March 31, 2025 | 61.63M | +4.8% | +2.8% |
| December 31, 2024 | 59.97M | +34.0% | +0.9% |
| September 30, 2024 | 59.45M | +34.2% | +0.9% |
| June 30, 2024 | 58.91M | +49.6% | +0.2% |
| March 31, 2024 | 58.80M | +59.3% | +31.4% |
| December 31, 2023 | 44.75M | +28.0% | +1.0% |
- Pyxis Oncology, Inc. showed an increase of +4.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Pyxis Oncology, Inc.’s shares outstanding has grown by 4762.2% (from 1.29 million shares to 62.69 million shares).
- The most recent figure is from Pyxis Oncology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: